Nancy Krueger - Net Worth and Insider Trading

Nancy Krueger Net Worth

The estimated net worth of Nancy Krueger is at least $70,141 dollars as of 2024-11-05. Nancy Krueger is the General Counsel of aTyr Pharma Inc and owns about 22,267 shares of aTyr Pharma Inc (ATYR) stock worth over $70,141. Details can be seen in Nancy Krueger's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nancy Krueger has not made any transactions after 2024-06-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Nancy Krueger

To

Nancy Krueger Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nancy Krueger owns 1 companies in total, including aTyr Pharma Inc (ATYR) .

Click here to see the complete history of Nancy Krueger’s form 4 insider trades.

Insider Ownership Summary of Nancy Krueger

Ticker Comapny Transaction Date Type of Owner
ATYR aTyr Pharma Inc 2020-05-20 See Remarks

Nancy Krueger Latest Holdings Summary

Nancy Krueger currently owns a total of 1 stock. Nancy Krueger owns 22,267 shares of aTyr Pharma Inc (ATYR) as of June 5, 2024, with a value of $70,141.

Latest Holdings of Nancy Krueger

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ATYR aTyr Pharma Inc 2024-06-05 22,267 3.15 70,141

Holding Weightings of Nancy Krueger


Nancy Krueger Form 4 Trading Tracker

According to the SEC Form 4 filings, Nancy Krueger has made a total of 2 transactions in aTyr Pharma Inc (ATYR) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in aTyr Pharma Inc is the acquisition of 5,000 shares on June 5, 2024, which cost Nancy Krueger around $9,300.

Insider Trading History of Nancy Krueger

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nancy Krueger Trading Performance

GuruFocus tracks the stock performance after each of Nancy Krueger's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nancy Krueger is -3.85%. GuruFocus also compares Nancy Krueger's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nancy Krueger within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Nancy Krueger's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Nancy Krueger

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -17.03 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -21.01 LIMIT LIMIT LIMIT LIMIT LIMIT

Nancy Krueger Ownership Network

Ownership Network List of Nancy Krueger

No Data

Ownership Network Relation of Nancy Krueger

Insider Network Chart

Nancy Krueger Owned Company Details

What does aTyr Pharma Inc do?

Who are the key executives at aTyr Pharma Inc?

Nancy Krueger is the See Remarks of aTyr Pharma Inc. Other key executives at aTyr Pharma Inc include Chief Financial Officer Jill Marie Broadfoot , Chief Medical Officer Sanjay Shukla , and director & CEO and Executive Chairman John Mendlein .

aTyr Pharma Inc (ATYR) Insider Trades Summary

Over the past 18 months, Nancy Krueger made 1 insider transaction in aTyr Pharma Inc (ATYR) with a net purchase of 5,000. Other recent insider transactions involving aTyr Pharma Inc (ATYR) include a net purchase of 65,000 shares made by Sanjay Shukla , a net purchase of 300,000 shares made by Paul Schimmel , and a net purchase of 3,410 shares made by Jill Marie Broadfoot .

In summary, during the past 3 months, insiders sold 0 shares of aTyr Pharma Inc (ATYR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,590 shares of aTyr Pharma Inc (ATYR) were sold and 425,000 shares were bought by its insiders, resulting in a net purchase of 423,410 shares.

aTyr Pharma Inc (ATYR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

aTyr Pharma Inc Insider Transactions

No Available Data

Nancy Krueger Mailing Address

Above is the net worth, insider trading, and ownership report for Nancy Krueger. You might contact Nancy Krueger via mailing address: C/o Atyr Pharma, Inc., 3545 John Hopkins Court, Suite 250, San Diego Ca 92121.